Press Releases
Relmada Therapeutics Provides Additional Details Regarding Upcoming R&D Day
Relmada Therapeutics to Showcase Breadth of Pipeline at Upcoming R&D Day
Relmada Therapeutics, Inc. Provides Update on Nasdaq Up-Listing Process
Relmada Therapeutics to Present at the 28th Annual ROTH Conference
Relmada Therapeutics Announces Publication of Full Results from Phase I Study Showing Treatment with d-Methadone to be Safe and Well Tolerated
Relmada Therapeutics to Present at the 18th Annual BIO CEO & Investor Conference
Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern
Relmada Therapeutics Selected to Present at 2016 Biotech Showcase™ in San Francisco
Relmada Therapeutics Successfully Completes Multiple Ascending Dose Study of d-Methadone for Neuropathic Pain
Relmada Therapeutics Announces Results of Annual Meeting of Stockholders
